We are live on ! Find out more
B

Bellecapital Portfolio holdings

AUM $625M
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.88%
AUM
$300M
AUM Growth
+$81.3M
Cap. Flow
+$53.7M
Cap. Flow %
17.92%
Top 10 Hldgs %
30.67%
Holding
195
New
35
Increased
77
Reduced
34
Closed
15

Top Buys

Rank Stock Value
1
ARKG icon
ARK Genomic Revolution ETF
ARKG
+$7.21M
2
TME icon
Tencent Music
TME
+$6.16M
3
MMYT icon
MakeMyTrip
MMYT
+$5.61M
4
ZTO icon
ZTO Express
ZTO
+$5.17M
5
HCAT icon
Health Catalyst
HCAT
+$3.76M

Sector Composition

Rank Sector Weight
1 Technology 20.52%
2 Consumer Discretionary 15.83%
3 Healthcare 10%
4 Communication Services 9.83%
5 Consumer Staples 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDS.A
151
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$302K 0.1%
8,597
-297
-3% -$9.27K
BIDU icon
152
Baidu
BIDU
$35.7B
$301K 0.1%
1,393
-355
-20% -$52.7K
NIO icon
153
NIO
NIO
$11.9B
$292K 0.1%
+6,000
New +$232K
CHI
154
Calamos Convertible Opportunities and Income Fund
CHI
$968M
$282K 0.09%
20,847
+395
+2% +$4.86K
YUMC icon
155
Yum China
YUMC
$15.7B
$279K 0.09%
4,890
KMB icon
156
Kimberly-Clark
KMB
$37.6B
$276K 0.09%
2,046
+4
+0.2% +$560
VGSH icon
157
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$271K 0.09%
4,403
PDLI
158
DELISTED
PDL BioPharma, Inc.
PDLI
$267K 0.09%
108,025
REGI
159
DELISTED
Renewable Energy Group, Inc.
REGI
$267K 0.09%
3,773
-4,969
-57% -$304K
FCX icon
160
Freeport-McMoran
FCX
$86.2B
$262K 0.09%
+10,050
New +$209K
GWPH
161
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$254K 0.08%
+2,199
New +$246K
TEVA icon
162
Teva Pharmaceuticals
TEVA
$40.4B
$252K 0.08%
26,100
+10,100
+63% +$96.8K
WPM icon
163
Wheaton Precious Metals
WPM
$49.7B
$252K 0.08%
6,450
BDX icon
164
Becton Dickinson
BDX
$46.4B
$250K 0.08%
1,025
IJH icon
165
iShares Core S&P Mid-Cap ETF
IJH
$121B
$241K 0.08%
+5,250
New +$221K
BKNG icon
166
Booking.com
BKNG
$156B
$238K 0.08%
+2,675
New +$206K
ECL icon
167
Ecolab
ECL
$79.8B
$238K 0.08%
1,100
NVDA icon
168
NVIDIA
NVDA
$4.6T
$227K 0.08%
17,360
+1,040
+6% +$13.9K
SPSB icon
169
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$219K 0.07%
6,985
-1,111
-14% -$34.8K
SHOP icon
170
Shopify
SHOP
$168B
$217K 0.07%
+2,060
New +$216K
MMM icon
171
3M
MMM
$91.8B
$211K 0.07%
+1,441
New +$205K
EWGS
172
DELISTED
iShares MSCI Germany Small-Cap ETF
EWGS
$210K 0.07%
+2,788
New +$186K
CRM icon
173
Salesforce
CRM
$154B
$202K 0.07%
+908
New +$221K
VGK icon
174
Vanguard FTSE Europe ETF
VGK
$30.1B
$202K 0.07%
3,350
-1,250
-27% -$70.4K
XLC icon
175
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
$202K 0.07%
2,995
-379
-11% -$24.1K

Similar funds

Bellecapital's Q4 2020 Portfolio in Review

As of Q4 2020, Bellecapital held 195 positions worth $300M, up 37% from $219M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bellecapital deployed $53.7M of net new capital in Q4 2020, opening 35 new positions and adding to 77 existing holdings. Its largest new stake was ARK Genomic Revolution ETF: 90,517 shares worth $8.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was SPDR Gold Trust, an estimated $1.3M trimmed.

  • Bellecapital's largest Q4 2020 buy was ARK Genomic Revolution ETF: 90,517 shares worth $8.44M.
  • Bellecapital added most to ZTO Express in Q4 2020, an estimated $5.17M increase.
  • Bellecapital's biggest Q4 2020 reduction was SPDR Gold Trust, cutting an estimated $1.3M.
  • Bellecapital fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $5.96M.
  • Bellecapital's ten largest holdings make up 31% of its $300M portfolio in Q4 2020.
  • Bellecapital opened 35 new positions and closed 15 in Q4 2020.
  • Bellecapital's portfolio value rose 37% quarter-over-quarter to $300M.

Based on Bellecapital's 13F filing for Q4 2020, filed 14 Jan 2021.